SUPPLEMENT

Q1 2020 — Supplemental Sales Data

Q1 2020PDF · 2 pages24 KB
Johnson & Johnson and Subsidiaries
Supplementary Sales Data
(Unaudited; Dollars in Millions)
2020 	2019 	Total 	Operations 	Currency
Sales to customers by
segment of business
Consumer Health
U.S. 	1,740	$ 	1,438 	21.0 % 	21.0 	-
International 	1,885 	1,880 	0.3 	3.9 	(3.6)
3,625 	3,318 	9.2 	11.3 	(2.1)
Pharmaceutical
U.S. 	6,061 	5,582 	8.6 	8.6 	-
International 	5,073 	4,662 	8.8 	12.0 	(3.2)
11,134 	10,244 	8.7 	10.1 	(1.4)
Medical Devices
U.S. 	2,898 	3,109 	(6.8) 	(6.8) 	-
International 	3,034 	3,350 	(9.4) 	(6.9) 	(2.5)
5,932 	6,459 	(8.2) 	(6.9) 	(1.3)
U.S. 	10,699 	10,129 	5.6 	5.6 	-
International 	9,992 	9,892 	1.0 	4.0 	(3.0)
Worldwide 	20,691	$ 	20,021 	3.3 % 	4.8 	(1.5)
Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely.
FIRST QUARTER
Percent Change

-- 1 of 2 --

Johnson & Johnson and Subsidiaries
Supplementary Sales Data
(Unaudited; Dollars in Millions)
2020 	2019 	Total 	Operations 	Currency
Sales to customers by
geographic area
U.S. 	10,699	$ 	10,129 	5.6 % 	5.6 	-
Europe 	4,827 	4,609 	4.7 	7.5 	(2.8)
Western Hemisphere excluding U.S. 	1,502 	1,503 	(0.1) 	8.5 	(8.6)
Asia-Pacific, Africa 	3,663 	3,780 	(3.1) 	(1.9) 	(1.2)
International 	9,992 	9,892 	1.0 	4.0 	(3.0)
Worldwide 	20,691	$ 	20,021 	3.3 % 	4.8 	(1.5)
Note: Percentages have been calculated using actual, non-rounded figures and, therefore, may not recalculate precisely.
FIRST QUARTER
Percent Change

-- 2 of 2 --